|

COP Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Cyclophosphamide, Oncovin (vincristine), and Prednisone

Pipeline

Phase 3: 1

Top Sponsors

  • Acrotech Biopharma Inc.1

Indications

  • Peripheral T Cell Lymphoma1
  • Cancer1

Clovis, California1 trial

To Evaluate Efficacy of Belinostat or Pralatrexate in Combination Against CHOP Alone in PTCL

University of California, San Francisco Fresno

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.